MGC Pharmaceuticals Valuation
| MGCLFDelisted Stock | USD 0.21 0.00 0.00% |
MGC Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of MGC Pharmaceuticals from inspecting the firm fundamentals such as Current Valuation of 24.97 M, return on asset of -0.45, and Operating Margin of (3.28) % as well as reviewing its technical indicators and probability of bankruptcy. . In general, most investors recommend locking in undervalued equities and disposing overvalued equities since, in the future, asset prices and their ongoing real values will come together.
Overvalued
Today
Please note that MGC Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of MGC Pharmaceuticals is based on 3 months time horizon. Increasing MGC Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the MGC otc stock is determined by what a typical buyer is willing to pay for full or partial control of MGC Pharmaceuticals. Since MGC Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MGC OTC Stock. However, MGC Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.21 | Real 0.19 | Hype 0.21 | Naive 0.21 |
The real value of MGC OTC Stock, also known as its intrinsic value, is the underlying worth of MGC Pharmaceuticals OTC Stock, which is reflected in its stock price. It is based on MGC Pharmaceuticals' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MGC Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MGC Pharmaceuticals helps investors to forecast how MGC otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MGC Pharmaceuticals more accurately as focusing exclusively on MGC Pharmaceuticals' fundamentals will not take into account other important factors: MGC Pharmaceuticals Total Value Analysis
MGC Pharmaceuticals is now expected to have takeover price of 24.97 M with market capitalization of 17.2 M, debt of 4.35 M, and cash on hands of 1.89 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MGC Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.97 M | 17.2 M | 4.35 M | 1.89 M |
MGC Pharmaceuticals Investor Information
The company recorded a loss per share of 0.01. MGC Pharmaceuticals had not issued any dividends in recent years. Based on the key indicators related to MGC Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, MGC Pharmaceuticals is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.MGC Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. MGC Pharmaceuticals has an asset utilization ratio of 20.56 percent. This implies that the OTC Stock is making $0.21 for each dollar of assets. An increasing asset utilization means that MGC Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.MGC Pharmaceuticals Ownership Allocation
MGC Pharmaceuticals secures a total of 2.87 Billion outstanding shares. MGC Pharmaceuticals owns 9.1 % of its outstanding shares held by insiders and 6.12 % owned by institutions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.MGC Pharmaceuticals Profitability Analysis
The company reported the revenue of 4.65 M. Net Loss for the year was (20.35 M) with profit before overhead, payroll, taxes, and interest of 562.87 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MGC Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MGC Pharmaceuticals and how it compares across the competition.
About MGC Pharmaceuticals Valuation
The otc valuation mechanism determines MGC Pharmaceuticals' current worth on a weekly basis. Our valuation model uses a comparative analysis of MGC Pharmaceuticals. We calculate exposure to MGC Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MGC Pharmaceuticals's related companies.MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia. Mgc Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.
8 Steps to conduct MGC Pharmaceuticals' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates MGC Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct MGC Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain MGC Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine MGC Pharmaceuticals' revenue streams: Identify MGC Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research MGC Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish MGC Pharmaceuticals' growth potential: Evaluate MGC Pharmaceuticals' management, business model, and growth potential.
- Determine MGC Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate MGC Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
MGC Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as MGC Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 2.6 B | |
| Forward Price Earnings | 15.1976 | |
| Retained Earnings | -98.3 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in MGC OTC Stock
If you are still planning to invest in MGC Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MGC Pharmaceuticals' history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |